Africa CDC Emergency Meeting on Large Outbreak of Non-Zaire Ebola In the DRC - U.S. CDC Airport Screening/Travel Restrictions

[Michael Coston]

Africa CDC Convenes Emergency Meeting After Reports of a Large Outbreak of Non-Zaire Ebola In the DRC

#19,160

While details remain scant, overnight Africa CDC released an urgent statement overnight on what appears to be an unusually large outbreak of a non-Zaire Ebola virus in Ituri province, Democratic Republic of the Congo; centered primarily in the Mongwalu and Rwampara health zones.

With the caveat that only 13 of 20 samples have tested positive - they report 246 suspected cases and 65 deaths - which (if correct) suggests this outbreak may have been ongoing for some time.​

The preliminary finding of a `non-Zaire' Ebola strain is noteworthy. While a more complete genomic analysis expected within the next 24 hours, the two biggest contenders are the Sudan Ebolavirus (SEBOV) and Bundibugyo Ebolavirus (BEBOV).

Previously, 15 of the 16 confirmed Ebola outbreaks in the DRC since 1976 have been Ebola Zaire, with one outlier, an outbreak of the Bundibugyo Ebolavirus in 2012.​

A non-Zaire ebolavirus could complicate matters, since the current Ebola vaccine is designed specifically for ZEBOV, and it is not expected to provide significant cross protection against other strains.

First, the statement from Africa CDC, after which I'll return with a bit more.

Africa CDC Calls Urgent Regional Coordination Meeting Following Ebola Virus Disease Outbreak in Ituri Province, DRC

Addis Ababa, Ethiopia / Kinshasa, DRC, 15 May 2026 — The Africa Centres for Disease Control and Prevention (Africa CDC) is closely monitoring the confirmed Ebola Virus Disease outbreak in Ituri province, Democratic Republic of the Congo, and is working with national authorities and partners to support a rapid, coordinated response.

Following consultations with the DRC’s Ministry of Health and National Public Health Institute, preliminary laboratory results from the Institut National de Recherche Biomédicale (INRB) have detected Ebola virus in 13 of 20 samples tested. The results suggest a non-Zaire ebolavirus, with sequencing ongoing to further characterise the strain. Results are expected within the next 24 hours with support from Africa CDC.

As of the latest update, about 246 suspected cases and 65 deaths have been reported, mainly in Mongwalu and Rwampara health zones. Four deaths have been reported among laboratory-confirmed cases. Suspected cases have also been reported in Bunia, pending confirmation.

Africa CDC is concerned about the risk of further spread due to the urban context of Bunia and Rwampara, intense population movement, mining-related mobility in Mongwalu, insecurity in affected areas, gaps in contact listing, infection prevention and control challenges, and the proximity of affected areas to Uganda and South Sudan.

In response, Africa CDC is convening an urgent high-level coordination meeting today, 15 May 2026, with health authorities from the DRC, Uganda and South Sudan, together with key partners including the World Health Organization, UNICEF, FAO, the United States CDC, the European CDC, China CDC, the Public Health Agency of Canada, Gilead Sciences, Merck & Co., Johnson & Johnson Innovative Medicine, Regeneron Pharmaceuticals, Roche, Abbott Laboratories, Cepheid, BioNTech, Moderna, Evotec Biologics, CEPI, Gavi, Médecins Sans Frontières, IFRC, the World Bank, the African Development Bank, Afreximbank, the Gates Foundation, the Wellcome Trust, and other partners.

The meeting will focus on immediate response priorities, cross-border coordination, surveillance, laboratory support, infection prevention and control, risk communication, safe and dignified burials, and resource mobilisation.

“Africa CDC stands in solidarity with the Government and people of the Democratic Republic of the Congo as they respond to this outbreak,” said H.E. Dr Jean Kaseya, Director General of Africa CDC. “Given the high population movement between affected areas and neighbouring countries, rapid regional coordination is essential. We are working with DRC, Uganda, South Sudan and partners to strengthen surveillance, preparedness and response, and to help contain the outbreak as quickly as possible.”

Africa CDC is preparing support across key response pillars, including coordination through emergency operations mechanisms, digital surveillance and data management, cross-border preparedness, laboratory coordination, infection prevention and control, risk communication and community engagement. In addition, Africa CDC will work with partners to assess the availability and appropriateness of medical countermeasures once sequencing results confirm the exact ebolavirus species.

Africa CDC is urging communities in affected and at-risk areas to follow guidance from national health authorities, report symptoms promptly, avoid direct contact with suspected cases, and support response teams working to protect communities. Additional information will be provided as they become available and as sequencing results are finalised.

About Ebola Virus Disease

Ebola Virus Disease is a severe and often fatal illness. It spreads through direct contact with the bodily fluids of infected persons, contaminated materials, or persons who have died from the disease. Early detection, prompt isolation and care, contact tracing, infection prevention and control, community engagement, and safe and dignified burials are critical to stopping transmission. WHO describes Ebola as spreading through direct contact with bodily fluids and contaminated surfaces or materials.​

There are 6 known types of Ebolaviruses, with the most recent (Bombali) discovered in 2018.

• Ebola virus (species Zaire ebolavirus)
• Sudan virus (species Sudan ebolavirus)
• Taï Forest virus (species Taï Forest ebolavirus, formerly Côte d’Ivoire ebolavirus)
• Bundibugyo virus (species Bundibugyo ebolavirus)
• Reston virus (species Reston ebolavirus)
• Bombali virus (species Bombali ebolavirus)

Of these, only 4 are known to infect and sicken humans (Bombali and Reston have yet to do so). These viruses are endemic in bats, can infect non-human primates and other mammalian hosts, and occasionally spill over into humans.

While most Ebola outbreaks are contained after a few dozen - or a few hundred - cases, the 2014-2016 West African outbreak spanned 3 countries, and claimed over 11,000 lives.

Exported cases outside of Africa are rare, but have been reported (see here, here, and here).​

All of which means we'll be keeping a close eye on this emerging regional public health emergency.



https://afludiary.blogspot.com/2026/05/africa-cdc-convenes-emergency-meeting.html

 

[Michael Coston]

CDC Statement on the Use of Public Health Travel Restrictions to Prevent the Introduction of Ebola Disease into the United States

Scheduled airline traffic around the world – Credit Wikipedia

#19,165

While reassuring the public that the current risk to Americans from the Ebola outbreak in the DRC is `low', yesterday the CDC announced enhanced screening of travelers and imposed `Entry restrictions on non-US passport holders' if they have visited Uganda, DRC, or South Sudan in the past 3 weeks.

This invocation of Title 42, and a de facto `travel ban' for non-US passport holders is noticeably more restrictive than what we saw during the 2014-2015 Ebola outbreak in West Africa (see CDC Statement On Airport Screening Of Arrivals From West Africa).​

First the CDC statement, after which I'll return more on the checkered history of interdicting diseases at ports of entry.

CDC Statement on the Use of Public Health Travel Restrictions to Prevent the Introduction of Ebola Disease into the United States

For Everyone
May 18, 2026

What to know

On May 18, 2026, CDC, DHS, and other appropriate federal agencies implemented enhanced travel screening, entry restrictions, and public health measures to prevent Ebola disease from entering the United States amid ongoing outbreaks in East and Central Africa.

Statement on Title 42 Order

Title 42 Order

Title 42 Order Suspending the Right to Introduce Certain Persons from Countries Where a Quarantinable Communicable Disease Exists

The Centers for Disease Control and Prevention (CDC), and the Department of Homeland Security (DHS), and other appropriate federal agencies, are taking proactive measures to protect the health and safety of the American public in response to ongoing Ebola Virus Disease (EVD) outbreaks.

Under authority granted by Sections 362 and 365 of the Public Health Service (PHS) Act, 42 U.S.C. §§ 265, 268, and their implementing regulations, CDC is implementing targeted public health measures intended to reduce the risk of Ebola disease caused by the Bundibugyo virus (EVD) by preventing its introduction into the United States. These actions are based on current epidemiological evidence, ongoing risk assessments, and the highly serious nature of EVD. This order will be in effect for 30 days, effective immediately.

Effective immediately, CDC will:

• Enhance public health screening and traveler monitoring for individuals arriving from areas affected by Ebola outbreaks in the region.
• Entry restrictions on non-US passport holders if they have been in Uganda, DRC, or South Sudan in the previous 21 days.
• Coordinate with airlines, international partners, and port-of-entry officials to identify and manage travelers who may have been exposed to Ebola virus.
• Enhance port health protection response activities, contact tracing, laboratory testing capacity, and hospital readiness nationwide.
• Continue deployment of CDC personnel to support outbreak containment efforts in affected regions.

At this time, CDC assesses the immediate risk to the general U.S. public as low, but we will continue to evaluate the evolving situation and may adjust public health measures as additional information becomes available.

If you have traveled through the affected countries you are encouraged to monitor CDC travel health notices and seek medical attention immediately if you develop symptoms consistent with Ebola, including fever, weakness, vomiting, diarrhea, or unexplained bleeding, within 21 days of travel to affected areas.​

As we discussed in 2014's The New Normal: The Age Of Emerging Disease Threats, the reality of life in this third decade of the 21st century is that disease threats that once were local, can now spread globally in a matter of hours or days.

Between asymptomatic (or presymptomatic) carriage, and long incubation periods, vast oceans and prolonged travel times no longer protect us against infected travelers crossing borders.​

Globally, airlines handle over 5 billion passengers and over 40 million flights per year; that's roughly 12 million passengers and 100,000 flights each day. In the U.S. there are roughly 160 airports which handle international flights.

With incubation periods that can range from a couple of days to several weeks, anyone who is recently exposed could easily change planes and continents several times before ever they ever show signs of illness.​

Previous failed attempts to prevent the spread of H1N1 pandemic flu and COVID illustrate just how difficult interdiction really is.

• In 2010's Japan: Quarantine At Ports Ineffective Against Pandemic Flu, we looked at a study which found for every person identified, and quarantined, by port authorities - researchers estimated 14 others infected by the virus entered undetected.

• In April of 2012, in EID Journal: Airport Screening For Pandemic Flu In New Zealand, we looked at a study that found that the screening methods used at New Zealand’s airport were inadequate to slow the entry of the 2009 pandemic flu into their country, detecting less than 6% of those infected.

• And in late 2020, a CDC MMWR Risk Assessment and Management of COVID-19 Among Travelers Arriving at Designated U.S. Airports, January 17–September 13, 2020, found that `Symptom-based screening programs are ineffective because of the nonspecific clinical presentation of COVID-19 and asymptomatic cases.'

None of this is to say there is no value in trying to detect, and quarantine, potentially infected travelers coming from an outbreak region; only that we need to temper our expectations.

Surveillance can often identify acutely ill individuals when they are likely to be the most contagious so they can be promptly isolated, and it can provide important surveillance information. And it might even help slow the rate of entry of an emerging disease into a region, allowing additional time to mount public health interventions.​

But as far as preventing an infectious disease like Ebola, MERS-CoV, or novel Flu from entering this - or any other country - airport screening is unlikely to provide much in the way of long-term protection.

The best place to try to stop the next pandemic is not at the inbound passenger gate, but in the places around the world where they are most likely to emerge.​

But in our increasingly chaotic and insular world, that goal seems less obtainable with every passing day.
​

https://afludiary.blogspot.com/2026/05/cdc-statement-on-use-of-public-health.html